{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:37:55Z","timestamp":1788381475639,"version":"build-2803163510"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00442","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T01:24:30Z","timestamp":1586222670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":171,"title":["Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools"],"prefix":"10.3389","volume":"11","author":[{"given":"Anne S.","family":"De Groot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Moise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres H.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Hindocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Fredric","family":"Hoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy R.","family":"Noe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayaka","family":"Kotraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Silk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ashfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Ardito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00262-012-1354-x","article-title":"Bioinformatics for cancer immunology and immunotherapy","volume":"61","author":"Charoentong","year":"2012","journal-title":"Cancer Immunol Immunother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.4049\/jimmunol.1900819","article-title":"A novel vaccine strategy to overcome poor immunogenicity of avian influenza vaccines through mobilization of memory CD4 T cells established by seasonal influenza","volume":"203","author":"DiPiazza","year":"2019","journal-title":"J Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/eji.201847852","article-title":"Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization","volume":"49","author":"Gage","year":"2019","journal-title":"Eur J Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.4161\/hv.25598","article-title":"Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1586\/14760584.2016.1123098","article-title":"T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity","volume":"15","author":"Moise","year":"2016","journal-title":"Exp Rev Vaccin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1080\/21645515.2015.1052197","article-title":"H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance","volume":"11","author":"Liu","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.4161\/hv.36134","article-title":"Immune camouflage: relevance to vaccines and human immunology","volume":"10","author":"De Groot","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2105-15-S4-S1","article-title":"Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage","volume":"15","author":"He","year":"2014","journal-title":"BMC Bioinform."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1016\/j.vaccine.2015.08.099","article-title":"Hit-and-run, hit-and-stay, and commensal bacteria present different peptide content when viewed from the perspective of the T cell","volume":"33","author":"He","year":"2015","journal-title":"Vaccine."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1080\/21645515.2015.1050572","article-title":"Preclinical development of HIvax: human survivin highly immunogenic vaccines","volume":"11","author":"Hoffmann","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41598-017-01372-5","article-title":"A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines","volume":"7","author":"Wada","year":"2017","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1016\/s0264-410x(03)00390-6","article-title":"Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach","volume":"21","author":"De Groot","year":"2003","journal-title":"Vaccine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ymeth.2004.06.003","article-title":"Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine","volume":"34","author":"De Groot","year":"2004","journal-title":"Methods."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1080\/21645515.2015.1061159","article-title":"iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines","volume":"11","author":"Moise","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/s0264-410x(98)00173-x","article-title":"Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix","volume":"16","author":"Schafer","year":"1998","journal-title":"Vaccine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1080\/21645515.2017.1329788","article-title":"An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice","volume":"13","author":"Bounds","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.vaccine.2005.01.059","article-title":"Developing an epitope-driven tuberculosis (TB) vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2174\/156652407780831584","article-title":"Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice","volume":"7","author":"McMurry","year":"2007","journal-title":"Curr Mol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1586\/14760584.2015.955478","article-title":"Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases","volume":"14","author":"Terry","year":"2015","journal-title":"Exp Rev Vaccin."},{"key":"B20","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.4049\/jimmunol.160.7.3363","article-title":"Several common HLA-DR types share largely overlapping peptide binding repertoires","volume":"160","author":"Southwood","year":"1998","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002510050594","article-title":"Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism","volume":"50","author":"Sette","year":"1999","journal-title":"Immunogenetics."},{"key":"B22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12859-015-0724-8","article-title":"Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method","volume":"16","author":"Guti\u00e9rrez","year":"2015","journal-title":"BMC Bioinform."},{"key":"B23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","article-title":"Mass Spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction","volume":"46","author":"Abelin","year":"2017","journal-title":"Immunity."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.vaccine.2011.02.019","article-title":"Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD8+ T cells against the swine-origin H1N1 influenza virus","volume":"29","author":"Schanen","year":"2011","journal-title":"Vaccine."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1016\/j.vaccine.2009.06.018","article-title":"In silico-accelerated identification of conserved and immunogenic variola\/vaccinia T-cell epitopes","volume":"27","author":"Moise","year":"2009","journal-title":"Vaccine."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1016\/j.vaccine.2007.01.039","article-title":"Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine","volume":"25","author":"McMurry","year":"2007","journal-title":"Vaccine."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e94974","DOI":"10.1371\/journal.pone.0094974","article-title":"Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fimmu.2019.00207","article-title":"Promiscuous Coxiella burnetii CD4 epitope clusters associated with human recall responses are candidates for a novel T-cell targeted multi-epitope Q fever vaccine","volume":"10","author":"Scholzen","year":"2019","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e00213","DOI":"10.1128\/IAI.00213-19","article-title":"Coxiella burnetii epitope-specific T-cell responses in patients with chronic Q fever","volume":"87","author":"Scholzen","year":"2019","journal-title":"Infect Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/hv.2869","article-title":"Confirmation of immunogenic consensus sequence HIV-1 T-cell epitopes in Bamako, Mali and Providence, Rhode Island","volume":"2","author":"Koita","year":"2006","journal-title":"Hum Vaccin"},{"key":"B31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4161\/hv.20528","article-title":"Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes","volume":"8","author":"De Groot","year":"2012","journal-title":"Hum Vaccin Immunother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tube.2004.09.005","article-title":"Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes","volume":"85","author":"McMurry","year":"2005","journal-title":"Tuberculosis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.vaccine.2010.10.064","article-title":"VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone","volume":"29","author":"Moise","year":"2011","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1016\/j.vaccine.2009.06.101","article-title":"Epitope-based vaccination against pneumonic tularemia","volume":"27","author":"Gregory","year":"2009","journal-title":"Vaccine."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.4161\/hv.26511","article-title":"Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.vaccine.2005.01.097","article-title":"HIV vaccine development by computer assisted design: the GAIA vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.vaccine.2010.12.130","article-title":"HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model","volume":"29","author":"Moss","year":"2011","journal-title":"Vaccine."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.4161\/21645515.2014.985498","article-title":"Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice","volume":"10","author":"Shattuck","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"B39","article-title":"Advanced and accelerated immunogenicity and human homology screening for biologic product candidates using the ISPRI toolkit","author":"De Groot","year":"","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cellimm.2007.02.006","article-title":"Evolutionary deimmunization: an ancillary mechanism for self-tolerance?","volume":"244","author":"De Groot","year":"2006","journal-title":"Cell Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.addr.2009.07.001","article-title":"T cell epitope: friend or foe? Immunogenicity of biologics in context","volume":"61","author":"Weber","year":"2009","journal-title":"Adv Drug Deliv Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1073\/pnas.95.7.3833","article-title":"T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin","volume":"95","author":"Congia","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12985-019-1156-2","article-title":"A candidate DNA vaccine encoding a fusion protein of porcine complement C3d-P28 and ORF2 of porcine circovirus type 2 induces cross-protective immunity against PCV2b and PCV2d in pigs","volume":"16","author":"Hou","year":"2019","journal-title":"Virol J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1002840","DOI":"10.1371\/journal.pcbi.1002840","article-title":"The two sides of complement C3d: evolution of electrostatics in a link between innate and adaptive immunity","volume":"8","author":"Kieslich","year":"2012","journal-title":"PLoS Comput Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/icb.2014.89","article-title":"C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells","volume":"93","author":"De Groot","year":"2015","journal-title":"Immunol Cell Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.immuni.2015.10.011","article-title":"CD4+ T cell tolerance to tissue-restricted self antigens is mediated by antigen-specific regulatory T cells rather than deletion","volume":"43","author":"Legoux","year":"2015","journal-title":"Immunity."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.immuni.2016.02.009","article-title":"Aire enforces immune tolerance by directing autoreactive T cells into the regulatory T cell lineage","volume":"44","author":"Malchow","year":"2016","journal-title":"Immunity."},{"key":"B48","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.20041033","article-title":"Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node","volume":"202","author":"Samy","year":"2005","journal-title":"J Exp Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.4161\/hv.24615","article-title":"The two-faced T cell epitope: examining the host-microbe interface with JanusMatrix","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhep.2014.08.02","article-title":"HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients","volume":"62","author":"Losikoff","year":"2015","journal-title":"J Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","article-title":"Activation of natural regulatory T cells by IgG Fc-derived peptide \u201cTregitopes\u201d","volume":"112","author":"De Groot","year":"2008","journal-title":"Blood."},{"key":"B52","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3324\/haematol.2018.195669","article-title":"Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A","volume":"104","author":"Hart","year":"2019","journal-title":"Haematologica."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.humimm.2014.10.012","article-title":"Tregitope: immunomodulation powerhouse","volume":"75","author":"Cousens","year":"2014","journal-title":"Hum Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/imm.12585","article-title":"T-cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome","volume":"148","author":"Bresciani","year":"2016","journal-title":"Immunology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0196551","DOI":"10.1371\/journal.pone.0196551","article-title":"Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopes","volume":"13","author":"Carrasco Pro","year":"2018","journal-title":"PLoS ONE."},{"key":"B56","doi-asserted-by":"publisher","first-page":"961752","DOI":"10.1155\/2010\/961752","article-title":"A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM)","volume":"2010","author":"Cohen","year":"2010","journal-title":"J Biomed Biotechnol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0159237","DOI":"10.1371\/journal.pone.0159237","article-title":"In vivo validation of predicted and conserved T Cell epitopes in a swine influenza model","volume":"11","author":"Guti\u00e9rrez","year":"2016","journal-title":"PLOS ONE"},{"key":"B58","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/irv.12513","article-title":"T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin","volume":"11","author":"Guti\u00e9rrez","year":"2017","journal-title":"Influenza Other Respir Viruses."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1016\/j.vaccine.2019.07.033","article-title":"Highly conserved influenza T cell epitopes induce broadly protective immunity","volume":"37","author":"Eickhoff","year":"2019","journal-title":"Vaccine."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.4161\/hv.34413","article-title":"VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever","volume":"10","author":"Leblanc","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"B61","article-title":"Vaccine optimization by identification characterization and downselection of human T cell epitopes from Plasmodium falciparum CSP","author":"Noe","year":"2019","journal-title":"Presented at American Society of Tropical Medicine and Hygiene; November 2019"},{"key":"B62","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/21645515.2018.1560772","article-title":"Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi","volume":"16","author":"Khan","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"B63","article-title":"3 in silico T cell epitope prediction identifies high value RH5 epitopes that correlate with response in vaccines","author":"Terry","year":"2018","journal-title":"Presented at American Society of Tropical Medicine and Hygiene, November 2018"},{"key":"B64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2010.09.013","article-title":"The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins","volume":"408","author":"Kennedy","year":"2010","journal-title":"Virology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1016\/j.vaccine.2019.06.044","article-title":"A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model","volume":"37","author":"Hewitt","year":"2019","journal-title":"Vaccine."},{"key":"B66","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood."},{"key":"B67","doi-asserted-by":"publisher","first-page":"197ra103","DOI":"10.1126\/scitranslmed.3006034","article-title":"Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells","volume":"5","author":"Cameron","year":"2013","journal-title":"Sci Transl Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12885-017-3854-8","article-title":"Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues","volume":"17","author":"Jaravine","year":"2017","journal-title":"BMC Cancer."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J Clin Investig."},{"key":"B70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00251-005-0781-7","article-title":"The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage","volume":"57","author":"Nielsen","year":"2005","journal-title":"Immunogenetics."},{"key":"B71","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cels.2018.05.014","article-title":"MHCflurry: open-source class I MHC binding affinity prediction","volume":"7","author":"O'Donnell","year":"2018","journal-title":"Cell Syst."},{"key":"B74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nbt.4313","article-title":"Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification","volume":"37","author":"Bulik-Sullivan","year":"2019","journal-title":"Nat Biotechnol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology."},{"key":"B76","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/9858","article-title":"Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices","volume":"17","author":"Sturniolo","year":"1999","journal-title":"Nat Biotechnol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.immuni.2019.08.012","article-title":"Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction","volume":"51","author":"Abelin","year":"2019","journal-title":"Immunity."},{"key":"B78","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1002829","DOI":"10.1371\/journal.pcbi.1002829","article-title":"Reliable B cell epitope predictions: impacts of method development and improved benchmarking","volume":"8","author":"Kringelum","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/B978-0-12-407190-2.00007-1","article-title":"Therapeutic cancer vaccines: past, present, and future","volume":"119","author":"Guo","year":"2013","journal-title":"Adv Cancer Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/intimm\/dxw027","article-title":"The present status and future prospects of peptide-based cancer vaccines","volume":"28","author":"Hirayama","year":"2016","journal-title":"Inter Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e1511506","DOI":"10.1080\/2162402X.2018.1511506","article-title":"Trial watch: peptide-based vaccines in anticancer therapy","volume":"7","author":"Bezu","year":"2018","journal-title":"Oncoimmunology."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00442\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T12:20:50Z","timestamp":1695990050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00442\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":82,"alternative-id":["10.3389\/fimmu.2020.00442"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00442","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"article-number":"442"}}